Berns, Els M J J <br/><br/>
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2003 
 - 1253-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--metabolism<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Multivariate Analysis<br/>Mutation<br/>Neoplasms--metabolism<br/>Odds Ratio<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Estrogen--biosynthesis<br/>Tamoxifen--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--biosynthesis<br/>Up-Regulation<br/>Vascular Endothelial Growth Factor A--biosynthesis